Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4102522
Max Phase: Preclinical
Molecular Formula: C44H54Cl2N12O7
Molecular Weight: 933.90
Molecule Type: Small molecule
Associated Items:
ID: ALA4102522
Max Phase: Preclinical
Molecular Formula: C44H54Cl2N12O7
Molecular Weight: 933.90
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(Cl)cc(Cl)c1CN(NC(=O)[C@H](C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
Standard InChI: InChI=1S/C44H54Cl2N12O7/c1-25(53-42(62)37(17-27-21-51-34-13-7-6-12-30(27)34)55-41(61)33(48)20-29-22-50-24-52-29)40(60)57-58(23-31-32(46)18-28(45)19-38(31)65-2)44(64)56-36(16-26-10-4-3-5-11-26)43(63)54-35(39(49)59)14-8-9-15-47/h3-7,10-13,18-19,21-22,24-25,33,35-37,51H,8-9,14-17,20,23,47-48H2,1-2H3,(H2,49,59)(H,50,52)(H,53,62)(H,54,63)(H,55,61)(H,56,64)(H,57,60)/t25-,33-,35-,36+,37+/m0/s1
Standard InChI Key: FFCDWHFXEUQTHJ-BFWLDDMUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 933.90 | Molecular Weight (Monoisotopic): 932.3615 | AlogP: 2.26 | #Rotatable Bonds: 22 |
Polar Surface Area: 297.57 | Molecular Species: BASE | HBA: 10 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 19 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.86 | CX Basic pKa: 10.45 | CX LogP: 0.48 | CX LogD: -2.03 |
Aromatic Rings: 5 | Heavy Atoms: 65 | QED Weighted: 0.04 | Np Likeness Score: -0.19 |
1. Chignen Possi K, Mulumba M, Omri S, Garcia-Ramos Y, Tahiri H, Chemtob S, Ong H, Lubell WD.. (2017) Influences of Histidine-1 and Azaphenylalanine-4 on the Affinity, Anti-inflammatory, and Antiangiogenic Activities of Azapeptide Cluster of Differentiation 36 Receptor Modulators., 60 (22): [PMID:29028172] [10.1021/acs.jmedchem.7b01209] |
Source(1):